Business, energy, technology, markets and global industry news from Business News Today

California Institute of Technology

PharmaDeviceNews California Institute of Technology
Aizen Therapeutics’ new oral peptide collaboration puts its DaX AI drug discovery platform to the test, with the partnership targeting next-generation oral biologics for immunology and neurology and offering up to $100 million in milestone potential per nominated target. Representative image.
Pharma & Biotech

Aizen Therapeutics just put a $100 million-per-target test on its AI-designed oral biologics platform

Aizen Therapeutics lands an oral peptide collaboration with several million dollars upfront and up to $100 million in milestones per target.

Read More